Association between pretreatment lymphocyte count and response to PD1 inhibitors in head and neck squamous cell carcinomas

by Won Jin Ho, Mark Yarchoan, Alex Hopkins, Ranee Mehra, Stuart Grossman, Hyunseok Kang
Published 2018-08-01

Ipilimumab-Induced Enteritis without Colitis: A New Challenge

by Marcus Messmer, Sunita Upreti, Yaman Tarabishy, Nikhilesh Mazumder, Reezwana Chowdhury, Mark Yarchoan, Matthias Holdhoff
Published 2016-11-01

Role of in silico structural modeling in predicting immunogenic neoepitopes for cancer vaccine development

by Neeha Zaidi, Mariya Soban, Fangluo Chen, Heather Kinkead, Jocelyn Mathew, Mark Yarchoan, Todd D. Armstrong, Shozeb Haider, Elizabeth M. Jaffee
Published 2020-09-01

Rapidly progressive metastatic cholangiocarcinoma in a postpartum patient with cystic fibrosis: a case report

by Sara W. Carson, Kelly E. Craven, David Nauen, Kristina Montemayor, Mark Yarchoan, William R. Burns, Christian A. Merlo, Natalie E. West
Published 2020-11-01

Chronic losartan administration reduces mortality and preserves cardiac but not skeletal muscle function in dystrophic mice.

by Lawrence T Bish, Mark Yarchoan, Meg M Sleeper, Jeffrey A Gazzara, Kevin J Morine, Pedro Acosta, Elisabeth R Barton, H Lee Sweeney
Published 2011-01-01

MEK inhibition suppresses B regulatory cells and augments anti-tumor immunity.

by Mark Yarchoan, Aditya A Mohan, Lauren Dennison, Teena Vithayathil, Amanda Ruggieri, Gregory B Lesinski, Todd D Armstrong, Nilofer S Azad, Elizabeth M Jaffee
Published 2019-01-01

Multi-omic profiling of lung and liver tumor microenvironments of metastatic pancreatic cancer reveals site-specific immune regulatory pathways

by Won Jin Ho, Rossin Erbe, Ludmila Danilova, Zaw Phyo, Emma Bigelow, Genevieve Stein-O’Brien, Dwayne L. Thomas, Soren Charmsaz, Nicole Gross, Skylar Woolman, Kayla Cruz, Rebecca M. Munday, Neeha Zaidi, Todd D. Armstrong, Marcelo B. Sztein, Mark Yarchoan, Elizabeth D. Thompson, Elizabeth M. Jaffee, Elana J. Fertig
Published 2021-05-01

A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer

by Mark Yarchoan, Chiung‐Yu Huang, Qingfeng Zhu, Anna K. Ferguson, Jennifer N. Durham, Robert A. Anders, Elizabeth D. Thompson, Noah S. Rozich, Dwayne L. Thomas II, Julie M. Nauroth, Christina Rodriguez, Arsen Osipov, Ana De Jesus‐Acosta, Dung T. Le, Adrian G. Murphy, Daniel Laheru, Ross C. Donehower, Elizabeth M. Jaffee, Lei Zheng, Nilofer S. Azad
Published 2020-02-01

Development, Practice Patterns, and Early Clinical Outcomes of a Multidisciplinary Liver Cancer Clinic

by Angela Y. Jia MD, PhD, Aleksandra Popovic BS, Aditya A. Mohan BS, Jane Zorzi BS, Paige Griffith MSN, AG-ACNP, BSN, Amy K. Kim MD, Robert A. Anders MD, PhD, Richard A. Burkhart MD, Kelly Lafaro MD, MPH, Christos Georgiades MD, PhD, Nilofer S. Azad MD, Robert P. Liddell MD, Marina Baretti MD, Ihab R. Kamel MD, PhD, Amol Narang MD, Mark Yarchoan MD, Jeffrey Meyer MD
Published 2021-04-01